Combined Anti-Cancer Effects of Platycodin D and Sorafenib on Androgen-Independent and PTEN-Deficient Prostate Cancer

Castration-resistant (androgen-independent) and PTEN-deficient prostate cancer is a challenge in clinical practice. Sorafenib has been recommended for the treatment of this type of cancer, but is associated with several adverse effects. Platycodin D (PD) is a triterpene saponin with demonstrated ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Zongliang, Song, Wei, Zhang, Yaowen, Wu, Changpeng, Zhu, Mingxing, Wang, He, Li, Na, Zhou, Yong, Xu, Hongxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138035/
https://www.ncbi.nlm.nih.gov/pubmed/34026624
http://dx.doi.org/10.3389/fonc.2021.648985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138035/
https://www.ncbi.nlm.nih.gov/pubmed/34026624
http://dx.doi.org/10.3389/fonc.2021.648985

Ejemplares similares